Search Login Register
Jaundice
Summary
Description:
A clinical manifestation of HYPERBILIRUBINEMIA, characterized by the yellowish staining of the SKIN; MUCOUS MEMBRANE; and SCLERA. Clinical jaundice usually is a sign of LIVER dysfunction.
Also Known As:
Icterus
Networked: 5932
relevant articles (237 outcomes,
283 trials/studies)
for this Disease
Key Drugs and Agents for Jaundice
Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
-
Bilirubin
:
48 outcomes 70 studies in 1121 results
: IBA
-
Prednisolone (Predate)
:
7 outcomes 1 study in 20 results
:
FDA 55
Generic
-
Ursodeoxycholic Acid (Urso)
:
6 outcomes 1 study in 22 results
:
FDA 9
Generic
-
Alkaline Phosphatase
:
5 outcomes 6 studies in 185 results
: IBA
-
Steroids
:
5 outcomes 3 studies in 40 results
: IBA
-
perfluoro- 2,2,2',2'- tetramethyl- 4,4'- bis(1,3- dioxolane)
:
5 outcomes in 29 results
: IBA
-
Enzymes
:
4 outcomes 1 study in 156 results
: IBA
-
Anti-Bacterial Agents (Antibiotics)
:
4 outcomes 1 study in 28 results
: IBA
-
Transaminases
:
3 outcomes 4 studies in 129 results
: IBA
-
Bile Acids and Salts (Bile Acids)
:
3 outcomes 2 studies in 39 results
: IBA
Show All >>
Diseases Related to Jaundice
-
Pruritus (Itching)
-
Obstructive Jaundice (Cholestatic Jaundice)
-
Fever (Fevers)
-
Neoplasms (Cancer)
-
Carcinoma (Carcinomatosis)
Show All >>
Key Therapies for Jaundice
Efficacy Chart >>
-
Stents
:
20 outcomes 4 studies in 195 results
-
Phototherapy (Light Therapy)
:
14 outcomes 28 studies in 267 results
-
Drug Therapy (Chemotherapy)
:
14 outcomes 1 study in 100 results
-
Liver Transplantation
:
11 outcomes 6 studies in 96 results
-
Cholecystectomy
:
6 outcomes 2 studies in 91 results
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.